DK1197223T3 - Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopati - Google Patents
Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopatiInfo
- Publication number
- DK1197223T3 DK1197223T3 DK00921056T DK00921056T DK1197223T3 DK 1197223 T3 DK1197223 T3 DK 1197223T3 DK 00921056 T DK00921056 T DK 00921056T DK 00921056 T DK00921056 T DK 00921056T DK 1197223 T3 DK1197223 T3 DK 1197223T3
- Authority
- DK
- Denmark
- Prior art keywords
- retinopathy
- prevention
- treatment
- pharmaceutical preparation
- preproliferative
- Prior art date
Links
- 206010012689 Diabetic retinopathy Diseases 0.000 title abstract 2
- 208000017442 Retinal disease Diseases 0.000 title abstract 2
- 206010038923 Retinopathy Diseases 0.000 title abstract 2
- 230000009034 developmental inhibition Effects 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 102000005862 Angiotensin II Human genes 0.000 abstract 1
- 101800000733 Angiotensin-2 Proteins 0.000 abstract 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 1
- 229950006323 angiotensin ii Drugs 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12149899 | 1999-04-28 | ||
| PCT/JP2000/002766 WO2000066161A1 (en) | 1999-04-28 | 2000-04-27 | Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1197223T3 true DK1197223T3 (da) | 2005-05-30 |
Family
ID=14812676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00921056T DK1197223T3 (da) | 1999-04-28 | 2000-04-27 | Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopati |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7064141B1 (https=) |
| EP (1) | EP1197223B1 (https=) |
| KR (1) | KR100865059B1 (https=) |
| CN (1) | CN1172719C (https=) |
| AT (1) | ATE289204T1 (https=) |
| AU (1) | AU774799B2 (https=) |
| BR (1) | BR0010084A (https=) |
| CA (1) | CA2371554C (https=) |
| CZ (1) | CZ301913B6 (https=) |
| DE (1) | DE60018186T2 (https=) |
| DK (1) | DK1197223T3 (https=) |
| ES (1) | ES2233362T3 (https=) |
| HU (1) | HU226948B1 (https=) |
| MX (1) | MXPA01010923A (https=) |
| NO (1) | NO327446B1 (https=) |
| NZ (1) | NZ514855A (https=) |
| PL (1) | PL196895B1 (https=) |
| PT (1) | PT1197223E (https=) |
| RU (1) | RU2239454C2 (https=) |
| SI (1) | SI1197223T1 (https=) |
| SK (1) | SK286859B6 (https=) |
| WO (1) | WO2000066161A1 (https=) |
| ZA (1) | ZA200108527B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4484427B2 (ja) * | 2001-12-03 | 2010-06-16 | 武田薬品工業株式会社 | インスリン抵抗性改善剤 |
| WO2003047573A1 (en) * | 2001-12-03 | 2003-06-12 | Takeda Chemical Industries, Ltd. | Insulin resistance improving agents |
| TW200304812A (en) * | 2002-03-08 | 2003-10-16 | Sankyo Co | An eye drop containing a tetrazole derivative |
| US8980870B2 (en) | 2002-09-24 | 2015-03-17 | Boehringer Ingelheim International Gmbh | Solid telmisartan pharmaceutical formulations |
| DE10335027A1 (de) * | 2003-07-31 | 2005-02-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Angiotensin II Rezeptor Antagonisten |
| TWI349549B (en) * | 2003-04-15 | 2011-10-01 | Sankyo Co | Medicament for treatment of intraocular angiopoietic disease |
| US20050038093A1 (en) * | 2003-05-02 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Treating diabetic retinopathy with angiotensin II receptor blockers |
| CN101035530B (zh) | 2004-08-31 | 2013-07-03 | 新南部创新有限公司 | Vegf抑制 |
| CN103083318A (zh) * | 2004-11-05 | 2013-05-08 | 贝林格尔.英格海姆国际有限公司 | 包含替米沙坦和氨氯地平的双层片剂 |
| RU2420280C2 (ru) * | 2005-04-21 | 2011-06-10 | Сантен Фармасьютикал Ко., Лтд | Терапевтическое средство против кератоконъюнктивального расстройства |
| CA2631231A1 (en) * | 2005-12-06 | 2007-06-14 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for corneal/conjuctival disease |
| US9066936B2 (en) * | 2007-03-28 | 2015-06-30 | Takeda Pharmaceutical Company Limited | Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9027211D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| DE4201554A1 (de) * | 1992-01-22 | 1993-07-29 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US5614519A (en) | 1991-02-06 | 1997-03-25 | Karl Thomae Gmbh | (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists |
| GB9110635D0 (en) * | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Chemical compounds |
| IL104755A0 (en) | 1992-02-17 | 1993-06-10 | Ciba Geigy Ag | Treatment of glaucoma |
| GB9223860D0 (en) * | 1992-11-13 | 1993-01-06 | Glaxo Group Ltd | Chemical compounds |
| CZ154994A3 (en) * | 1993-07-02 | 1995-09-13 | Senju Pharma Co | Visual hypotensive agent |
| JPH0789957A (ja) * | 1993-09-22 | 1995-04-04 | Nissan Chem Ind Ltd | ビフェニルメチルアミン誘導体 |
| CA2181461A1 (en) * | 1994-02-08 | 1995-08-17 | Alica Huxley | Treatment of normotensive glaucoma with angiotensin ii antagonists |
| JPH09210183A (ja) * | 1996-01-31 | 1997-08-12 | Suzuki Motor Corp | 動力伝達装置 |
| AU726694B2 (en) * | 1996-03-29 | 2000-11-16 | Smithkline Beecham Corporation | Eprosartan dihydrate and a process for its production and formulation |
| PL189066B1 (pl) * | 1996-04-05 | 2005-06-30 | Takeda Pharmaceutical | Kompozycja farmaceutyczna do zapobiegania lub zwalczania chorób związanych z angiotensyną II oraz stosowanie związków do wytwarzania leku do zapobiegania lub zwalczania chorób związanych z angiotensyną II |
| TW416953B (en) * | 1996-09-25 | 2001-01-01 | Takeda Chemical Industries Ltd | Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use |
| EP0855392A3 (de) | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| CA2294515C (en) * | 1997-06-27 | 2007-08-28 | Smithkline Beecham Corporation | Eprosartan monohydrate |
| IT1292437B1 (it) * | 1997-06-30 | 1999-02-08 | Zambon Spa | Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti |
| BR9811926A (pt) * | 1997-08-06 | 2000-08-22 | Smithkline Beecham Corp | Complexo de neutralização de carga de eprosartan arginila e um processo para a sua produção e formulação |
| KR20010086245A (ko) | 1998-03-04 | 2001-09-10 | 다케다 야쿠힌 고교 가부시키가이샤 | Ａⅱ 길항제용 서방성 제제, 그것의 제조 및 용도 |
| NZ509260A (en) | 1998-07-10 | 2003-09-26 | Novartis Ag | Pharmaceutical composition containing valsartan and a calcium channel blocker |
| FR2783422A1 (fr) * | 1998-09-21 | 2000-03-24 | Sanofi Sa | Composition pharmaceutique contenant un antagoniste des recepteurs at1 de l'angiotensine ii et un antiagregant plaquettaire |
| JP2000159671A (ja) * | 1998-12-01 | 2000-06-13 | Takeda Chem Ind Ltd | 血管新生阻害剤 |
-
2000
- 2000-04-27 EP EP00921056A patent/EP1197223B1/en not_active Expired - Lifetime
- 2000-04-27 CN CNB008067783A patent/CN1172719C/zh not_active Expired - Fee Related
- 2000-04-27 DE DE60018186T patent/DE60018186T2/de not_active Expired - Lifetime
- 2000-04-27 CZ CZ20013804A patent/CZ301913B6/cs not_active IP Right Cessation
- 2000-04-27 SI SI200030651T patent/SI1197223T1/xx unknown
- 2000-04-27 WO PCT/JP2000/002766 patent/WO2000066161A1/ja not_active Ceased
- 2000-04-27 DK DK00921056T patent/DK1197223T3/da active
- 2000-04-27 ES ES00921056T patent/ES2233362T3/es not_active Expired - Lifetime
- 2000-04-27 NZ NZ514855A patent/NZ514855A/xx not_active IP Right Cessation
- 2000-04-27 AU AU41434/00A patent/AU774799B2/en not_active Ceased
- 2000-04-27 MX MXPA01010923A patent/MXPA01010923A/es active IP Right Grant
- 2000-04-27 PT PT00921056T patent/PT1197223E/pt unknown
- 2000-04-27 RU RU2001132073/15A patent/RU2239454C2/ru not_active IP Right Cessation
- 2000-04-27 BR BR0010084-6A patent/BR0010084A/pt not_active Application Discontinuation
- 2000-04-27 US US09/958,740 patent/US7064141B1/en not_active Expired - Fee Related
- 2000-04-27 CA CA002371554A patent/CA2371554C/en not_active Expired - Fee Related
- 2000-04-27 SK SK1545-2001A patent/SK286859B6/sk not_active IP Right Cessation
- 2000-04-27 PL PL350554A patent/PL196895B1/pl not_active IP Right Cessation
- 2000-04-27 HU HU0200890A patent/HU226948B1/hu not_active IP Right Cessation
- 2000-04-27 AT AT00921056T patent/ATE289204T1/de not_active IP Right Cessation
- 2000-04-27 KR KR1020017013765A patent/KR100865059B1/ko not_active Expired - Fee Related
-
2001
- 2001-10-17 ZA ZA200108527A patent/ZA200108527B/en unknown
- 2001-10-26 NO NO20015257A patent/NO327446B1/no not_active IP Right Cessation
-
2006
- 2006-04-19 US US11/406,345 patent/US20060189669A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9908004A (pt) | Composto, composição e método para prevençãoou supressão de uma infecção viral | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| DE69829846D1 (de) | Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität | |
| GB9801690D0 (en) | Therapeutic agents | |
| PT1200412E (pt) | Agentes anti-proliferativos de imidazole | |
| NO20052580D0 (no) | Blandinger for behandling av infeksjon av Flavivirida viruser | |
| EE200200172A (et) | Ühendid isheemia ravimiseks | |
| HRP20050516B1 (hr) | N-alkil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi | |
| DE60332562D1 (de) | Therapeutische Piperazinverbindungen | |
| NZ515392A (en) | Respiratory syncytial virus replication inhibitors | |
| ATE425139T1 (de) | Benzamidinderivate | |
| IT1311922B1 (it) | Composti farmaceutici. | |
| BR0309278A (pt) | Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto | |
| EA200300716A1 (ru) | Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6 | |
| DK1197223T3 (da) | Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopati | |
| ATE248822T1 (de) | Partikel mit kontrollierter freisetzungsrate | |
| BR0215067A (pt) | Piridoquinoxalinas antivirais | |
| NO331012B1 (no) | N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
| TR199901017A2 (xx) | B�cek ilac� terkibi. | |
| BR0207102A (pt) | Forma cristalina, composição farmacêutica, uso de uma forma cristalina, e, método para a prevenção ou o tratamento de doença | |
| BRPI0411040A (pt) | n-alquinil-2-heteroariloxialquilamidas para uso como fungicidas | |
| WO2001011968A3 (en) | Heterocyclic spiro compounds as pesticides | |
| BR0007395B1 (pt) | compostos de s-nitrosotióis como agentes para o tratamento de disfunções circulatórias. | |
| DK1553938T3 (da) | Anvendelse af epothilonderivater til behandling af hyperparathyroidisme | |
| WO2001070706A3 (en) | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |